ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 479

Protein Carbamylation Is Induced By Activated Neutrophil: Ex Vivo Analysis

Shuichiro Nakabo1, Koichiro Ohmura1, Shuji Akizuki1, Nobuo Kuramoto1, Kosaku Murakami2, Ran Nakashima2, Motomu Hashimoto3, Hajime Yoshifuji1, Masao Tanaka3 and Tsuneyo Mimori1, 1Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 2Clinical Immunology and Rheumatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 3Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Neutrophil Extracellular Traps, post-translational modification and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Protein carbamylation is induced by activated neutrophil: ex vivo analysis

Background/Purpose:

Anti-carbamylated protein (anti-CarP) antibodies were reported to be detected in 45% of rheumatoid arthritis (RA) patients [1]. We previously reported that carbamylated albumin (CarALB) was one of the target antigens of anti-CarP antibodies, and serum myeloperoxidase (MPO) level was elevated in rheumatoid arthritis patients with anti-CarALB antibody [2]. Protein carbamylation occurs by cyanate which MPO produces from thiocyanate (SCN–) and hydrogen peroxide (H2O2), and MPO abundantly exists in neutrophil. Therefore, neutrophil is a strong candidate for the production of carbamylated antigen. The purpose of this study is to demonstrate that activated neutrophil induces protein carbamylation.

Methods:

Human neutrophils were isolated from whole blood by ficoll-dextran methods. They were pre-treated for 30 min at 37ºC in RPMI medium with or without 10ƒÊM diphenyleneiodonium (DPI), which inhibits NADPH-dependent reactive oxygen species (ROS) production. Subsequently, they were incubated overnight at 37 ºC in RPMI medium containing 0.01mg/mL ALB with or without 10ƒÊM DPI, 20nM phorbol 12-myristate 13-acetate (PMA) and 100ƒÊM potassium thiocyanate (KSCN). Then proteins in the medium were collected by trichloroacetic acid/acetone precipitation. The carbamylation of ALB was confirmed by Western blotting using anti-carbamyl-lysine (CBL) polyclonal antibody. MPO in the medium was detected by Western blotting using anti-MPO polyclonal antibody.

Results:

ALB was carbamylated only when both neutrophil and KSCN were present (Figure 1, lanes 4 and 5). Although the carbamylation occurred in the medium both with and without PMA, the level of the carbamylation was much higher in the medium with PMA (lane 5) than without PMA (lane 4). Carbamylation was inhibited by the presence of DPI, which diminishes ROS (lanes 7 and 8). MPO was released into the culture supernatant from the neutrophils (Figure 2, lane 2), and its release was accelerated by PMA (lanes 3 and 5), but attenuated by DPI (lanes 7 and 8).

Conclusion:

ALB in the culture medium was carbamylated by neutrophil. Given that PMA induces ROS production of neutrophil, and this reaction subsequently increases the MPO release, our data suggest that carbamylation is dependent on ROS and MPO from neutrophil. Addition of KSCN was necessary. This is the first report that showed direct relationship between neutrophil and protein carbamylation.

Reference:

[1] Shi J. Proc Natl Acad Sci U S A. 2011. [2] Nakabo S. Rheumatology (Oxford). 2017.

Figure 1: Western blotting of carbamylated albumin

ƒXƒ‰ƒCƒh2

Figure 2: Western blotting of MPO


Disclosure: S. Nakabo, None; K. Ohmura, None; S. Akizuki, None; N. Kuramoto, None; K. Murakami, None; R. Nakashima, None; M. Hashimoto, None; H. Yoshifuji, None; M. Tanaka, None; T. Mimori, None.

To cite this abstract in AMA style:

Nakabo S, Ohmura K, Akizuki S, Kuramoto N, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Mimori T. Protein Carbamylation Is Induced By Activated Neutrophil: Ex Vivo Analysis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/protein-carbamylation-is-induced-by-activated-neutrophil-ex-vivo-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/protein-carbamylation-is-induced-by-activated-neutrophil-ex-vivo-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology